Kusajili – Clinical trials directory

Result of your search per sponsor: Cephalon Europe, A Division of Cephalon UK Limited

Woman and Man Max 99 years
Cephalon Europe, A Division of Cephalon UK Limited Update Il y a 4 ans

A 6 month open-label, flexible-dosage study to assess the safety and effectiveness of PROVIGIL® (Modafinil) treatment in children and adolescents with excessive sleepiness associated with narcolepsy or obstructive sleep apnea/hypopnea To evaluate the safety and tolerability of treatment with Provigil in children and adolescents with excessive sleepiness (ES) associates with narcolepsy or obstructive sleep apnea/hypopnea syndrome (O...

Country None
organs None
Specialty None

unknown

More information